Clinical Trial Update: A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic study comparing SCT400 with rituximab in patients with B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• SCT400

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: B-cell Non Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN